Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.140
-0.060 (-2.73%)
At close: Jul 14, 2025, 4:00 PM
2.170
+0.030 (1.40%)
Pre-market: Jul 15, 2025, 4:30 AM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $728.16 million as of July 14, 2025. Its market cap has decreased by -3.09% in one year.
Market Cap
728.16M
Enterprise Value
277.90M
1-Year Change
-3.09%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $728.16M, an increase of 317.34%. That is a compound annual growth rate of 34.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 748.58M | -16.38% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |